Journal
/
/
专访:糖脂抗原提呈CD1d及NKT细胞活化治疗潜力
JoVE Journal
Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Biology
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
DOI:

18:08 min

December 31, 2007

Chapters

  • 00:00Introduction
  • 00:44Physiological Role of CD1
  • 04:52CD1d Tetramers
  • 06:57Use of CD1d Tetramers in the Lab
  • 08:46CD1d Tetramer Generation
  • 11:40Therapeutic Utility of NKT Cells
  • 14:43Mucosal Immunity
  • 16:13Future of Immunology

Summary

Automatic Translation

自然杀伤T细胞(NKT),癌症autioimmunity监管,清除感染,并发展artheriosclerotic斑块的免疫反应的关键因素。在这次采访中,米奇Kronenberg讨论他的实验室的努力去了解通过糖脂抗原激活NKT细胞的机制。

Related Videos

Read Article